Related Experiment Video

Updated: Jun 16, 2026

Targeted and Selective Treatment of Pluripotent Stem Cell-derived Teratomas Using External Beam Radiation in a Small-animal Model
05:08

Targeted and Selective Treatment of Pluripotent Stem Cell-derived Teratomas Using External Beam Radiation in a Small-animal Model

Published on: February 17, 2019

Clostridial spores to treat solid tumours - potential for a new therapeutic modality

Asferd Mengesha1, Jou Z Wei, Shu-Feng Zhou

  • 1Griffith University, Southport, Qld, Australia.

Current Gene Therapy
|February 18, 2010
PubMed

Insights

Oncolytic Clostridia, particularly their spores, show promise as cancer therapies by targeting and destroying tumors. Advances in genetic engineering are enhancing their potential as effective oncolytic gene delivery vectors for clinical use.

Area of Science:

  • Microbiology
  • Cancer Therapy
  • Biotechnology

Background:

  • Oncolytic Clostridia are re-emerging as potent cancer therapeutics.
  • Clostridial spores exploit the tumor microenvironment for tumor cell lysis.
  • Their unique characteristics make them suitable for cancer treatment.

Purpose of the Study:

  • To review the distinct traits of Clostridia as oncolytic agents.
  • To describe the therapeutic potential of Clostridial spores.
  • To summarize recent advances in Clostridia-based cancer therapy.

Main Methods:

  • Review of existing literature on Clostridia in cancer therapy.
  • Analysis of Clostridial spore properties and tumor microenvironment interactions.
  • Examination of genetic engineering tools like ClosTron for vector development.

Main Results:

  • Clostridia possess innate tumor-targeting and lysis capabilities.
  • They offer advantages as gene delivery vectors due to capacity and extracellular nature.
  • Genetic engineering advancements are improving their therapeutic efficacy.

Conclusions:

  • Clostridial spores demonstrate unique therapeutic effects not achievable with other modalities.
  • Recent progress highlights their viability as clinical therapeutic candidates.
  • Further research is needed to realize the full clinical potential of oncolytic Clostridia.

More Related Videos

Method for Novel Anti-Cancer Drug Development using Tumor Explants of Surgical Specimens09:26

Method for Novel Anti-Cancer Drug Development using Tumor Explants of Surgical Specimens

Published on: July 29, 2011

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts11:15

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Published on: September 1, 2018

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...